Literature DB >> 29222552

Animal Models of Retinal Vein Occlusion.

Meiaad Khayat1,2, Noemi Lois1, Michael Williams3, Alan W Stitt1.   

Abstract

Purpose: To provide a comprehensive and current review on the available experimental animal models of retinal vein occlusion (RVO) and to identify their strengths and limitations with the purpose of helping researchers to plan preclinical studies on RVO.
Methods: A systematic review of the literature on experimental animal models of RVO was undertaken. Medline, SCOPUS, and Web of Science databases were searched. Studies published between January 1, 1965, and March 31, 2017, and that met the inclusion criteria were reviewed. The data extracted included animal species used, methods of inducing RVO, and the clinical and histopathologic features of the models, especially in relation to strengths, limitations, and faithfulness to clinical sequelae.
Results: A total of 128 articles fulfilling the inclusion criteria were included. Several species were used to model human branch and central RVO (BRVO; CRVO) with nonhuman primates being the most common, followed by rodents and pigs. BRVO and CRVO were most commonly induced by laser photocoagulation and all models showed early features of clinical disease, including retinal hemorrhages and retinal edema. These features made many of the models adequate for studying the acute phase of BRVO and CRVO, although macular edema, retinal ischemia, and neovascular complications were observed in only a few experimental animal models (laser-induced model in rodents, pigs, and nonhuman primates, diathermy-induced model in pigs, and following intravitreal injection of PD0325901 in rabbits for BRVO; and in the laser-induced model in rodents, rabbits, and nonhuman primates, diathermy-induced model in nonhuman primates, following permanent ligation of the central retinal vein in nonhuman primates, and with intravitreal injection of thrombin in rabbits for CRVO). Conclusions: Experimental animal models of RVO are available to study the pathogenesis of this disease and to evaluate diagnostic/prognostic biomarkers and to develop new therapeutics. Data available suggest laser-induced RVO in pigs and rodents to be overall the best models of BRVO and the laser-induced RVO rodents the best model for CRVO.

Entities:  

Mesh:

Year:  2017        PMID: 29222552     DOI: 10.1167/iovs.17-22788

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

1.  Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability.

Authors:  Crystal Colón Ortiz; Anna Potenski; Jaqueline M Lawson; Jade Smart; Carol M Troy
Journal:  J Vis Exp       Date:  2021-08-06       Impact factor: 1.424

2.  The Changes in Blood Flow Seen in the Eye after Foot Acupuncture Treatment in Mice.

Authors:  Anri Nishinaka; Koki Nitta; Takashi Seki; Hideaki Hara; Masamitsu Shimazawa
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-06       Impact factor: 2.629

3.  Time course of collateral vessel formation after retinal vein occlusion visualized by OCTA and elucidation of factors in their formation.

Authors:  Hajime Takahashi; Kazuki Nakagawa; Haruhiko Yamada; Hidetsugu Mori; Shimpei Oba; Keiko Toyama; Kanji Takahashi
Journal:  Heliyon       Date:  2021-01-05

4.  Arteriovenous crossing in retinal vessels of mice, rats, and pigs.

Authors:  Gottfried Martin; Kira L Wefelmeyer; Felicitas Bucher; Günther Schlunck; Hansjürgen T Agostini
Journal:  Mol Vis       Date:  2020-10-15       Impact factor: 2.367

Review 5.  Angiopoietin/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data.

Authors:  Antonia M Joussen; Federico Ricci; Liliana P Paris; Claudia Korn; Carlos Quezada-Ruiz; Marco Zarbin
Journal:  Eye (Lond)       Date:  2021-02-09       Impact factor: 3.775

6.  Intravitreal Administration Effect of Adipose-Derived Mesenchymal Stromal Cells Combined with Anti-VEGF Nanocarriers, in a Pharmaceutically Induced Animal Model of Retinal Vein Occlusion.

Authors:  Eleni Gounari; Anastasia Komnenou; Evangelia Kofidou; Stavroula Nanaki; Dimitrios Bikiaris; Stavroula Almpanidou; Kokkona Kouzi; Vasileios Karampatakis; George Koliakos
Journal:  Stem Cells Int       Date:  2022-02-23       Impact factor: 5.443

7.  Rapid reduction of macular edema due to retinal vein occlusion with low-dose normobaric hyperoxia.

Authors:  Jorge G Arroyo; Brendan Seto; Keiko Yamada; Ke Zeng; Robert Minturn; Colin A Lemire
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-02-22       Impact factor: 3.117

8.  Gene expression profile analysis of the rabbit retinal vein occlusion model.

Authors:  Takuma Neo; Makoto Gozawa; Yoshihiro Takamura; Masaru Inatani; Masaya Oki
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

9.  Longitudinal Changes in Retinal Blood Flow in a Feline Retinal Vein Occlusion Model as Measured by Doppler Optical Coherence Tomography and Optical Coherence Tomography Angiography.

Authors:  Takanari Wada; Youngseok Song; Tsuneaki Oomae; Kenji Sogawa; Takafumi Yoshioka; Seigo Nakabayashi; Kengo Takahashi; Tomofumi Tani; Akihiro Ishibazawa; Satoshi Ishiko; Akitoshi Yoshida
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

Review 10.  VEGFR1 signaling in retinal angiogenesis and microinflammation.

Authors:  Akiyoshi Uemura; Marcus Fruttiger; Patricia A D'Amore; Sandro De Falco; Antonia M Joussen; Florian Sennlaub; Lynne R Brunck; Kristian T Johnson; George N Lambrou; Kay D Rittenhouse; Thomas Langmann
Journal:  Prog Retin Eye Res       Date:  2021-02-25       Impact factor: 21.198

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.